The Study of Vitamin D Supplement Effect on Improvement of Glycemic Indexes in Type 2 Diabetics
Phase 3
- Conditions
- Type 2 diabetes.Non-insulin-dependent diabetes mellitus
- Registration Number
- IRCT201011185191N6
- Lead Sponsor
- Cellular Molecular Research Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Patient's consent for participation in the study; Final diagnosis of Type 2 diabetes based on standard criteria; having no advanced nephrology and liver diseases as well as any other chronic diseases based on patient biography and clinical examination; having 0.7.5% = HBA1C = 7%. Exclusion criteria: Non-satisfaction of the patient for participation in the study; any chronic debilitive critical diseases based on patient biography and clinical examination; improper diabetes control HBA1C>7.5%; taking any calcium and vitamin D supplement during the last six months.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Measure of glycosylated hemoglobin (HbA1c). Timepoint: 3 months. Method of measurement: Laboratory.;Fasting glucose levels. Timepoint: 3 months. Method of measurement: Laboratory.;Glucose levels 2 hours after a meal. Timepoint: 3 months. Method of measurement: Laboratory.;Total cholesterol and triglyceride levels and LDL-C and HDL-C. Timepoint: 3 months. Method of measurement: Laboratory.
- Secondary Outcome Measures
Name Time Method Vitamin D level. Timepoint: 3 months. Method of measurement: Laboratory.